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Abstract—Implantable neural interfaces have evolved in the
past decades from stimulation-only devices to closed-loop record-
ing and stimulation systems, allowing both for more targeted
therapeutic techniques and more advanced prosthetic implants.
Emerging applications require multi-module active implantable
devices with intrabody power and data transmission. This
distributed approach poses a new set of challenges related
to inter-module connectivity, functional reliability and patient
safety. This paper addresses the ground referencing challenge in
active multi-implant systems, with a particular focus on neural
recording devices. Three different grounding schemes (passive,
drive, and sense) are presented and evaluated in terms of both
recording reliability and patient safety. Considerations on the
practical implementation of body potential referencing circuitry
are finally discussed, with a detailed analysis of their impact on
the recording performance.
I. INTRODUCTION
In the past few decades, Implantable Medical Devices
(IMDs) have shown remarkable success both as therapeutic
devices in treating debilitating conditions, and as prosthetic
devices, in restoring functions by bypassing dysfunctional
organs/pathways. The vast majority of clinical grade IMDs
are electrical stimulators. A well known example is the cardiac
pacemaker, which uses periodic electrical pulses as a stimu-
lation means for heart contraction [1]. More recently, neuro-
modulation devices such as cochlear implants for deaf people
and deep brain stimulators (DBS) for Parkinson’s disease and
essential tremor (ET), have demonstrated significant impact to
the quality of life of millions of patients [2], [3]. Besides these
examples, implantable devices for treatment of Epilepsy have
proven to be effective therapeutic solutions, with vagus nerve
stimulation (VNS) implants from Cyberonics playing a key
role [4]. Such neuroprosthetic IMDs are typically implanted
in the upper chest and based on active electronics enclosed
in a metallic or ceramic can, which houses also the battery.
Implantable leads are used as means for reaching the area to
stimulate and contact electrodes are responsible for delivering
the electrical pulse to the target tissue.
The need for both stimulation and recording of the biosignal
activity, often a requirement in modern therapeutic techniques,
have caused a recent surge in the generation of closed-loop
neuroprostheses. This relatively new category of implantable
devices, in addition to stimulation, also introduces the need
for front end sensing, signal conditioning, and real-time pro-
cessing. [5], [6]. Recently FDA-approved and now clinically-
available examples of such devices include the closed-loop
DBS Activa PC+S system from Medtronic and the responsive
neurostimulation (RNS) system for refractory partial epilepsy
implemented by NeuroPace [7], [8].
Closed-loop applications are now requiring more interfac-
ing channels (both for recording and stimulation) and at








































Fig. 1. Comparison between different IMD generations: (a) single-module
pace-making stimulation implant, (b) single-module closed-loop stimulation
and recording implant, and (3) multi-module closed-loop implant system.
the connectivity, for example, the number of implantable
leads, and conductors in each lead, the number of electrical
connections into a hermetic package, the challenge of trying
to observe microvolt-level biopotential signals through length
leads. Additionally, surgical and safety considerations place
additional requirements on performing certain functions in
certain locations. For example, a chest-mounted IMD can
occupy more volume (i.e. larger battery) and dissipate more
power (i.e. more capacity for on-board processing) than one
mounted in the head.
To address this, a new generation of implantable medical
devices is now emerging. Instead of the centralised approach
that uses a single active implantable device, the system is
now being partitioned and distributed across multiple active
implantable devices each with specific functions, and located
at different sites, e.g. [9], [10]. This approach addresses some
of the limitations of single-module implants, however it poses
a new set of challenges, mainly related to inter-module connec-
tivity, functional reliability and patient safety. The implantable
leads are now additionally used to facilitate transfer power
between modules and for bidirectional communication [11].
Moreover, having distinct active modules implies the need
for electrical isolation from each other to avoid direct current
paths between them. This means each implantable module
has its own power domain, and therefore different reference
potentials between the electronic circuits (module grounds).
This paper identifies the ground referencing challenge in
multi-module active implants and discusses three different
grounding configurations for distributed neural implants, with
particular focus on their impact to the recording performance
and on device safety. The remainder of this paper is organised
as follows: Section II describes the multi-module implant
configuration, discussing key challenges when dealing with
multiple power domains in an implant; Section III presents
three different grounding schemes for dealing with this; Sec-
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Fig. 2. Concept of the multi-module implantable system. (a) Conceptual body model with of a distributed implant system; (b) iter-module connectivity (one
central implant, multiple peripheral implants) and; (c) block diagram of internal structure of both central and peripheral implants and their interfacing.
performance, safety); and Section V concludes the paper.
II. MULTI-MODULE ACTIVE NEURAL IMPLANTS
The system concept of the multi-implant system is illus-
trated in Fig. 2.b. The typical configuration comprises of
one central implant, or central unit, and multiple smaller
peripheral implants, or peripheral units, each located in close
proximity to the target interface sites. The former includes
the energy source (battery), power management circuitry, a
control and processing unit, and communication interfaces to
transmit wireless data externally and to communicate with the
peripheral units through an intrabody network. Although there
are several research groups investigating different methods
of implementing wireless intrabody networks, all clinically-
applicable devices currently require a wired connection be-
tween the individual modules. We will thus focus only on
a wireline connection. This is based on multi-conductor im-
plantable leads serving as communication channel (bidirec-
tional) and power delivery medium (from central to periph-
eral). At the ‘receiving’ end of this network, the peripheral
units must also contain an intra-body communication interface,
to interact with the network and to retrieve power. This will
power up: (1) the front-end function-specific units, which can
be both recording and stimulation; (2) the data conversion
circuitry (analog-to-digital and digital-to-analog); and (3) the
digital processing unit (Fig. 2.c).
A. Module Ground Referencing
In order to avoid a DC voltage bias across the conductors
in the implantable lead [12], and thus to maintain the charge
balance over time, power transmission schemes based on AC-
coupling are typically required in wired implant systems. This
precludes unwanted current paths from being formed between
different modules if damage of the insulation occurs. Accord-
ingly, AC/DC power domain conversion is implemented at the
peripheral side, generating a suitable DC supply voltage for
the front-end circuitry (Vdr - Vss), hence the module ground
rail (GndP = Vss), as shown in Fig. 3.a. [13]. This however,
creates DC isolation between central and peripheral implants
and therefore the electric potential of the module ground at the
peripheral implant N (GndPn) is not referred to the module
ground at the central implant (GndC).
By definition, implantable neural systems are placed inside
the human body, hence surrounded by biological tissue. Unlike
bedside hospital equipment, they are not directly connected to
the AC electric power coming from the mains (grid power),
they instead receive the electrical energy from a battery
enclosed within the implant or inductively from external power
sources. Unless the body touches the mains, the generated
potential rails are to be considered floating and not referenced
to the earth ground. The human body, however has its own
electric potential, body potential (BP), as shown in Fig. 2.a.
In electrical equilibrium (no current flow within the body),
such potential is considered the same over the whole body.
The BP has to be taken into consideration when dealing
with ground referencing in the neural implant system, as the
potential displacement of GndC and GndP from BP may have
a significant impact on: (1) safety of the patient (2) device
reliability, and (3) recording quality.
B. Grounding Impact on Recording Quality, Device Reliability
and Patient Safety
Implantable devices that sense biopotential signals, for ex-
ample neural recording systems, connect the sensing electrodes
that are in direct contact with the tissue, i.e. thus with BP, to
high impedance amplifier inputs. The observed biopotential
thus consists of this large baseline (BP) in addition to a
relatively weak AC signal (desired activity to be recorded).
A differential front-end amplifier is typically used to record
such signals, for example, in intracortical recording: this
senses and amplifies the difference in potential between two
electrode, while suppressing the common potential (common-
mode rejection, CMR). Moreover, to deal with the unknown
DC offset between the BP and recording circuit (power rails
Vdr and Vss/GndP), biopotential amplifier inputs are typically
AC coupled through capacitors. This leaves the BP having
a relatively high impedance to the recording circuit power
rails that effectively makes the tissue an ‘antenna’ for picking
up common-mode noise. It is thus essential to maintain a
relatively low impedance connection between the recording
circuit power rails and BP to attenuate the observed common
mode noise (at the amplifier inputs). Furthermore, in terms
of safety, a significant difference in electric potential between
GndC/GndP and BP (voltage) may lead to corrosion/failure
of encapsulation that would result in current flow into/from the
tissue exceeding the safety limits defined by the international
directives on active implantable devices.
For these reasons, an appropriate ground referencing scheme
is required in order to ensure good recording quality, but also






















































Fig. 3. Peripheral neural recording implant system: (a) power recovery and
Vdr and Vss DC rail generation; (b) distributed multi-module brain implants.
III. GROUND REFERENCING SCHEMES
Given that the central implant is enclosed within a case
serving as DC electrical screen from the body, with no direct
contact between internal circuitry and body tissue, there is no
need for GndC to be referenced to BP. On the other hand, the
peripheral implants have a direct path to the tissue through
the recording electrodes (Fig. 3.b), hence the need for proper
referencing of the DC rails to the body potential.
The most common and simple ground referencing con-
figuration is the passive connection of a peripheral device
power rail (either Vdr or Vss) to the body potential. In acute
experiments, the peripheral module ground GndP is often
shorted directly to the BP through a ground electrode, so to
reference the tissue to the lowest potential of the module. The
passive scheme is represented in (Fig. 4.a) with a resistive
divider. The ‘short’ is obtained from this when considering
either R1 = 0, R2 = ∞ (BP = Vdr), or vice-versa
(BP = Vss). Depending on the initial value of the body
potential, compared to the shorted rail, there will be current
flow from/to the tissue in order to equilibrate the potential
between the two nodes. In the scenario of multiple peripheral
implants close to each other, it is usually preferred to short
the BP to all the peripheral grounds (GndP1, ...GndPN ).
The second category of body referencing circuits (BRC) is
composed of active components. This can be further divided
into two topologies: (1) driving BRC; and (2) sensing BRC.
The driving reference circuit is shown in Fig. 4.b consisting of
a reference voltage generation circuit (e.g. a resistor divider)
and an output buffer with a low output impedance to drive the
BP . In both passive and drive schemes, there is current flow
between implant and tissue. This ensures the voltage between
BP and GndP to be fixed, thus reducing the common-mode
signal at the input of the recording amplifier, at the expense of
current exchange between peripheral module and body. Unlike
for the passive scheme, the BRC with driver/buffer ensures
that the current is always injected into or out of the tissue
providing a level of stability to the source (peripheral implant)
from inherent fluctuations of the potential around BP .
Fig. 4.c presents a third scheme, based on a sensing BRC:
this time, a front-end sensing circuit is used as body refer-
ence circuit to measure the BP instant value and references
the peripheral rails level accordingly. The sensed voltage
Body Reference Circuit - Drive








































Fig. 4. Different grounding schemes: (a) passive; (b) drive; (c) sense.
(BP − GndP ) can thus be sent to the recording amplifier,
which uses it to adjust the input biasing point of the latter. By
doing so, the body potential fluctuation itself, seen as common-
mode from the recording input electrodes, is employed in fact
as part of the common-mode rejection of the amplifier.
IV. DISCUSSION
A. Insights to Practical Implementation
So far in the paper, the interfacing between the BRCs and
the body has been considered as ideal, with negligible parasitic
elements and considering an ideal body potential electrode
(BPE). When practically implementing the circuits in a specific
technology and connecting them to the biological tissue, new
challenges arise due to: (1) electrode interface (metal-tissue)
non-idealities and; (2) circuit implementation constraints.
The electrical model of the electrode needs to be taken
into account when evaluating the impact of the ground ref-
erencing in the different schemes, both for recording quality
and safety limitations of current injection. A simplified model
is presented in Fig. 5. Also, capacitive coupling and current
leakage from the power rails, represented by Rleak and Ccoup,
affect the implant-tissue interfacing. This depends mainly on
encapsulation and circuit technology. The latter introduces
another interfacing aspect: typically, in CMOS technology,
integrated circuits require electrostatic discharge (ESD) pro-
tection at the interfacing pads, in order to prevent device
malfunction or breakdown. This is usually implemented using
reverse-biased pn-junction diodes, which ensure the potential
at the pad doesn’t exceed the upper and lower limits of the
power rails (V ss < Vp < V dr). Such diodes (D1 and D2
Vdr
Vss
if BP < Vss











































Fig. 5. Practical implementation interfacing of the body reference circuit
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Fig. 6. Common-mode signal path in an experimental setup. Noise sources
(VNS) are observed at the recording amplifier inputs via stray noise coupling
impedance (ZNS). The purpose of the body reference circuit is to shunt this
common-mode signal to recording amplifier ground such that it is attenuated at
the recording amplifier input. There is essentially a potential divider between
ZNS and (ZBODY−ELE +ZBRC). It is therefore essential to maintain a
low impedance BP drive relative to the recording circuit ground.
in Fig. 5) add to the parasitic impedances of the implant-
tissue interface, nevertheless, they prove to be advantageous
in clamping the body-potential within the implant rail-to-rail
range by providing a ‘weak’ leakage path.
B. Recording Performance
The three ground referencing schemes proposed in the
previous section give a different contribution to the neural
recording performance depending on the BRC implementation.
As shown in Fig. 6, where a schematics of BP to V ss
path is illustrated, the BRC and BPE impedances intervene
in the modification of such BP to V ss total impedance. By
maintaining the latter a low impedance path, thus reducing
the BRC common-mode gain ABRC−CM , the common-mode
fluctuations seen at the recording amplifier inputs are mini-
mized. However due to the frequency response of the BRC,
ABRC−CM may increase with frequency and possibly reach
to its maximum theoretical value of 0 dB (open circuit), i.e.
the common-mode noise add directly on the recording inputs
(Vin and Vref ) through the recording path. This is represented
in the example plot in Fig. 7 by the effective CMRR at
frequency f2. On the other hand, a zero impedance BRC (short
circuit) would reduce to 0 the VNS potential division on BP,
thus cancelling out the common-mode signal. This scenario is
theoretically possible, however, due to parasitic and electrode
impedances, it remains a practical implementation challenge.
C. Safety Considerations
Besides altering the neural recording performance, the
chosen grounding scheme and the technology features are
key aspects for body safety requirements, since they de-
fine the electrical behaviour at the implant-body interface
(BP − GndP potential difference and current flow). Except
for its intended function, active IMDs are required to be
electrically neutral when in contact with the body and the
maximum current density at the surface of any electrode is
set to ≤0.75µA/mm2 according to the directive in [14]. For
this reason, current limiters are necessary when employing
driving ground referencing topologies, alongside with implant
encapsulation and implant-to-implant electrical isolation.
V. CONCLUSION
This paper has described the key design considerations
in developing next generation multi-module neural implants.
Such systems need to cross-reference isolated power supplies,















Fig. 7. Common-mode Rejection Ratio (CMRR) of Recording Amplifier
and Common-mode gain of Body Reference Circuit (BRC) with the effective
observable CMRR being the difference between these responses. The BRC
configuration, i.e. impedance/drivability of BP relative to recording amplifier
ground, determines the magnitude and frequency dependence of the common-
mode signal observed at the amplifier inputs (Vin and Vref). This is critical
for experimental design.
to the power rails of the individual modules. Three different
grounding schemes have been identified based on shorting,
sensing, and driving the body potential. The function of these
schemes have been analysed by considering the coupling
of common-mode interference to the recording inputs. It is
revealed how ensuring a relatively low impedance path to
the recording circuit ground has the effect of attenuating
the common-mode observed at the electrode inputs, thus
improving recording quality. Finally, the practical and safety
considerations are assessed – in particular, due to the fact they
exchange electrical current with the body, it is essential to
guarantee operation within safe limits.
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